CaDi introduces tonic for gut immunity
Cambridge Diagnostic Imaging (CaDi) is launching Lycobiotic Flight™, a tonic for gut immunity, which helps to prepare passengers for long haul flights. The tonic boosts gut immunity to support the body resistance to unavoidable health risk factor inflight and in the days following.
"One of the main barriers in the way of the growth of air travel at a time when we are fighting with infections, including COVID-19, is passenger concern about health safety on board the plane as the existing air filtration does not give sufficient confidence," reads the August 20 press release. It continues: "Extra protection is very important during these times, however, support of the immune system is important at all times."
According to clinical trial referenced in the press release, it was shown that Lycobiotic is 1,000 to 4,000 times stronger than fibre, gives a wake-up boost for good bacteria in the gut and can stimulate the population of probiotic bacteria, in particular Bifidobacteria. Daily intake of the tonic at least 14 days before flight can help to boost gut immunity and support passenger health for upcoming travel.
“The travel industry has changed now and for a long time to come - Lycobiotic Flight™ is a perfect solution that helps to adapt to new realities. It will be available in Autumn 2020 and can be bought for airline miles. At the moment we are in negotiations with major airlines to choose the one for exclusive partnership for the next year”– said Alexey Shulepov, CEO of CaDi.
